Bone Biologics Corporation (BBLG)
Automate Your Wheel Strategy on BBLG
With Tiblio's Option Bot, you can configure your own wheel strategy including BBLG - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol BBLG
- Rev/Share 0.0
- Book/Share 0.9145
- PB 6.4628
- Debt/Equity 0.0
- CurrentRatio 12.5899
- ROIC -1.6766
- MktCap 3221972.0
- FreeCF/Share -1.1773
- PFCF -0.8597
- PE -2.5164
- Debt/Assets 0.0
- DivYield 0
- ROE -2.2835
- Rating C
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 3
- P/B Score 4
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
Bone Biologics Announces 1-for-6 Reverse Stock Split
Published: June 06, 2025 by: Business Wire
Sentiment: Neutral
BURLINGTON, Mass.--(BUSINESS WIRE)--Bone Biologics Corporation (“Bone Biologics” or the “Company”) (Nasdaq: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets, today announced a planned reverse stock split of its shares of common stock at a ratio of 1-for-6. The reverse stock split will take effect as of 12:01 a.m. ET, on Tuesday, June 10, 2025, and shares of Bone Biologics are expected to trade on a post-split basis on Nasdaq under the existing trading symbol, “BBLG,”.
Read More
About Bone Biologics Corporation (BBLG)
- IPO Date 2021-10-13
- Website https://www.bonebiologics.com
- Industry Medical - Devices
- CEO Mr. Jeffrey Frelick
- Employees 2